Lytix Biopharma AS (FRA:6BG)

Lytix Biopharma AS Revenue

Lytix Biopharma AS had revenue of 377.00K NOK in the twelve months ending September 30, 2025, down -96.50% year-over-year. In the year 2024, Lytix Biopharma AS had annual revenue of 11.13M with 178.98% growth.

• Revenue (ttm): 377.00K NOK
• Revenue Growth: -96.50%
• P/S Ratio: 1,886.58
• Revenue / Employee: 53.86K NOK
• Employees: 7
• Market Cap: 60.69M EUR

Revenue Chart

* This company reports financials in NOK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.13M	7.14M	178.98%
Dec 31, 2023	3.99M	-7.04M	-63.82%
Dec 31, 2022	11.03M	-8.28M	-42.87%
Dec 31, 2021	19.31M	15.23M	373.91%
Dec 31, 2020	4.07M	-2.27M	-35.73%